Sasano H, Garrett C T
Curr Top Pathol. 1992;85:357-72. doi: 10.1007/978-3-642-75941-3_12.
Evidence is increasing that proto-oncogenes and cancer suppressor genes are involved in the development and/or progression of gynecological malignancies. While histopathologic examination remains an indispensable tool of the surgical pathologist in the diagnosis and evaluation of patients with gynecological malignancies, the advancement to technology and the development of new knowledge regarding neoplastic transformation are providing a basis for new opportunities to improve patients care. These new opportunities will depend on the use of the skills and reagents developed in the basic medical science laboratories. Thus, it is important for those in the field of diagnostic pathology to begin to acquire a knowledge of proto-oncogenes and cancer suppressor genes as well as a basic understanding of the techniques used to detect and evaluate them.
越来越多的证据表明,原癌基因和抑癌基因参与了妇科恶性肿瘤的发生和/或发展。虽然组织病理学检查仍然是外科病理学家诊断和评估妇科恶性肿瘤患者不可或缺的工具,但技术的进步以及有关肿瘤转化的新知识的发展为改善患者护理提供了新的机会。这些新机会将取决于基础医学实验室所开发的技术和试剂的应用。因此,诊断病理学领域的人员开始了解原癌基因和抑癌基因,并对用于检测和评估它们的技术有基本的认识非常重要。